|
시장보고서
상품코드
2079632
혈청 젖산 검사 시장 동향, 경쟁 구도 및 예측(2033년)Serum Lactate Testing Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
혈청 젖산 검사 세계 시장은 의료 종사자들이 중환자 치료, 응급 의료 및 패혈증 관리 분야에서 신속 진단 검사의 중요성을 점점 더 강조함에 따라 꾸준한 성장을 이룰 것으로 예측됩니다. 해당 시장은 2026년 2억 1,000만 달러에서 2033년까지 3억 346만 달러로 확대될 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 5.4%를 나타낼 것으로 전망됩니다. 패혈증 발생률 증가, 중환자 치료 인프라 확충, 그리고 현장 진단(POC) 기술의 보급 확대가 세계 시장의 지속적인 성장을 뒷받침할 것으로 예측됩니다.
소개
혈청 젖산 검사는 조직의 산소 공급 상태를 평가하고, 패혈증, 패혈성 쇼크, 외상, 심장 응급 상황, 호흡 부전 등 생명을 위협하는 상태를 감지하기 위한 필수적인 진단 도구로 자리 잡고 있습니다. 의료진은 혈청 젖산 수치 측정 결과를 바탕으로 적시에 임상적 판단을 내리고, 질환의 중증도를 평가하며, 치료 효과를 모니터링함으로써 환자의 생존율을 높이고 있습니다.
진단 기술, 휴대용 분석기, 자동 검사 시스템 및 현장 진단(Point-of-Care) 검사 기기의 지속적인 발전으로 인해, 혈청 젖산 검사는 더욱 신속하고 정확해졌으며, 병원, 응급실, 중환자실, 외래 진료 등 각 현장에서 널리 활용되고 있습니다. 헬스케어 시스템에서 조기 진단과 근거 기반 치료 프로토콜이 점점 더 중요시됨에 따라, 첨단 혈청 젖산 검사 솔루션에 대한 수요는 계속해서 견조할 것으로 예측됩니다.
시장 동향
혈청 젖산 검사 시장은 응급의료 및 중환자 치료 현장에서 신속 진단 검사의 도입이 확대됨에 따라 꾸준한 성장을 이루고 있습니다. 병원에서는 검사 결과 보고 시간을 단축하는 고급 분석 장비와 현장 진단 플랫폼을 도입하고 있으며, 이를 통해 임상의들은 적시에 치료를 시작하여 환자의 예후를 개선할 수 있게 되었습니다.
응급의료 및 중환자 치료 분야에서 젖산 수치를 기반으로 한 치료에 대한 인식이 높아짐에 따라, 의료 기관들은 일상적인 임상 프로토콜의 일환으로 혈청 젖산 검사를 표준화하고 있습니다. 동시에, 휴대용 분석기 및 연속 모니터링 기술 덕분에 검사의 적용 범위는 중앙 검사실에 그치지 않고 외래 진료, 재택치료, 스포츠 의학, 원격 의료 현장으로 확대되고 있습니다.
자동화, 디지털 연결, 무선 데이터 전송 및 분석 정확도 향상에 중점을 둔 기술 혁신을 통해 검사실의 효율성은 지속적으로 향상되고 있으며, 임상 현장에서의 보다 광범위한 도입이 촉진되고 있습니다.
시장 성장 촉진요인
시장 성장을 주도하는 주요 요인 중 하나는 신속한 진단과 지속적인 환자 모니터링이 필요한 패혈증 및 기타 중증 질환으로 인한 전 세계적 부담이 증가하고 있다는 점입니다. 조기 혈청 젖산 평가는 고위험 환자 선별, 치료 방침 결정 및 임상 예후 개선에 있어 매우 중요한 역할을 수행하며, 응급 의료 및 중환자 치료에서 필수적인 요소로 자리 잡고 있습니다.
헬스케어 인프라, 중환자실 및 첨단 진단실험실에 대한 투자 확대 역시 최신 혈청 젖산 검사 솔루션에 대한 수요 증가에 기여하고 있습니다. 의료 서비스 제공업체들은 워크플로우의 효율성을 높이고 임상적 의사결정을 개선하는 통합형 진단 플랫폼을 도입하는 한편, 검사실의 기능 확충을 추진하고 있습니다.
또한, 현장 진단 검사(Point-of-Care)에 대한 수요가 증가함에 따라, 각 제조업체들은 응급실, 구급차, 지방 의료시설, 재난 대응 현장 등에서 신속하고 신뢰할 수 있는 젖산 측정이 가능한 소형 휴대용 분석기 개발을 추진하고 있습니다. 헬스케어 서비스 강화 및 질병 조기 발견 능력 향상을 목표로 한 정부의 이니셔티브 또한 시장 성장을 더욱 뒷받침하고 있습니다.
비즈니스 기회
혈청 젖산 검사 시장은 연속 모니터링 기술, 웨어러블 바이오센서, AI를 활용한 진단 플랫폼의 개발을 통해 큰 비즈니스 기회를 내포하고 있습니다. 헬스케어 시스템이 디지털 헬스 생태계를 점점 더 많이 도입함에 따라, 제조업체들에게는 젖산 검사를 전자의무기록(EHR), 원격 환자 모니터링 플랫폼, 임상 의사결정 지원 시스템과 통합할 기회가 생기고 있습니다.
신흥 경제국에서도 정부가 의료 서비스의 현대화와 첨단 진단 서비스에 대한 접근성 확대에 지속적으로 투자하고 있어, 큰 성장 가능성이 기대됩니다. '재택 병원' 프로그램, 원격 의료, 원격 환자 모니터링의 도입이 확대됨에 따라, 휴대하기 편리하고 사용하기 쉬운 혈청 젖산 검사 기기에 대한 새로운 수요가 발생할 것으로 예측됩니다.
합리적인 가격에 고정밀도를 자랑하며 디지털 연결 기능을 갖춘 진단 솔루션에 주력하는 제조업체는 선진국과 개발도상국의 헬스케어 시장 모두에서 시장 입지를 강화할 것으로 예측됩니다.
지역별 분석
북미는 선진적인 의료 인프라, 패혈증 관리 프로토콜의 광범위한 도입, 그리고 현장 진단 기술의 높은 보급률에 힘입어 계속해서 전 세계 혈청 젖산 검사 시장을 주도하고 있습니다. 탄탄한 보험 환급 제도와 중환자 치료 진단 분야에 대한 지속적인 투자가 해당 지역 시장에서 이 회사의 리더십을 더욱 공고히 하고 있습니다.
유럽은 확립된 의료 시스템, 패혈증 조기 발견에 대한 임상적 인식의 제고, 검사실의 현대화 및 진단 기술 혁신에 대한 지속적인 투자 덕분에 여전히 중요한 시장으로 자리 잡고 있습니다.
동아시아에서는 의료비 증가, 병원 인프라 개선, 주요 의료시설에서의 첨단 진단 기술 도입 확대 등을 배경으로 견조한 성장이 예상됩니다.
남아시아 및 오세아니아는 의료 인프라 확충, 응급 의료 서비스에 대한 정부 투자 증가, 그리고 최첨단 진단 장비에 대한 접근성 향상으로 인해 유망한 지역 시장으로 부상하고 있습니다.
라틴아메리카와 중동 및 아프리카에서는 의료 서비스 접근성이 개선되고 있으며, 병원들이 첨단 진단 기술과 중환자 치료 시설에 대한 투자를 지속하고 있어 꾸준한 시장 성장이 예상됩니다.
경쟁 구도
세계 혈청 젖산 검사 시장은 적정 수준의 통합이 진행되고 있으며, 주요 기업들은 기술 혁신, 진단 정확도, 디지털 통합 및 종합적인 서비스 제공을 통해 경쟁을 펼치고 있습니다. 각 기업은 분석 장치의 성능 향상, 휴대성 개선, 그리고 병원 정보 시스템 및 커넥티드 헬스케어 플랫폼과의 원활한 통합을 실현하기 위해 연구 개발에 지속적으로 투자하고 있습니다.
전략적 제휴, 규제 당국의 승인, 신제품 출시, 인수합병, 그리고 신흥 헬스케어 시장 진출은 업계 각사가 경쟁력을 강화하고 세계 사업 확장을 위해 지속적으로 채택하고 있는 주요 전략입니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 세계 혈청 젖산 검사 시장 전망, 2020-2033년
제4장 북미 혈청 젖산 검사 시장 전망, 2020-2033년
제5장 유럽 혈청 젖산 검사 시장 전망, 2020-2033년
제6장 아시아태평양 혈청 젖산 검사 시장 전망, 2020-2033년
제7장 라틴아메리카 혈청 젖산 검사 시장 전망, 2020-2033년
제8장 중동 및 아프리카 혈청 젖산 검사 시장 전망, 2020-2033년
제9장 경쟁 구도
제10장 부록
JHS 26.07.13The global Serum Lactate Testing Market is expected to witness steady growth as healthcare providers increasingly emphasize rapid diagnostic testing for critical care, emergency medicine, and sepsis management. According to the latest study by Fairfield Market Research, the market is projected to grow from US$ 210 Million in 2026 to US$ 303.46 Million by 2033, registering a CAGR of 5.4% during the forecast period. Rising incidences of sepsis, expanding critical care infrastructure, and increasing adoption of point-of-care (POC) diagnostic technologies are expected to support sustained market expansion worldwide.
Introduction
Serum lactate testing has become an indispensable diagnostic tool for evaluating tissue oxygenation and detecting life-threatening conditions such as sepsis, septic shock, trauma, cardiac emergencies, and respiratory failure. Healthcare professionals rely on serum lactate measurements to make timely clinical decisions, assess disease severity, monitor treatment response, and improve patient survival outcomes.
Continuous advancements in diagnostic technologies, portable analyzers, automated laboratory systems, and point-of-care testing devices are making serum lactate testing faster, more accurate, and widely accessible across hospitals, emergency departments, intensive care units, and outpatient settings. As healthcare systems increasingly prioritize early diagnosis and evidence-based treatment protocols, demand for advanced serum lactate testing solutions is expected to remain strong.
Market Insights
The Serum Lactate Testing Market is experiencing consistent growth due to the increasing adoption of rapid diagnostic testing across critical care and emergency medicine environments. Hospitals are integrating advanced analyzers and point-of-care platforms that provide faster turnaround times, enabling clinicians to initiate timely interventions and improve patient outcomes.
Growing awareness of lactate-guided therapy in emergency and intensive care medicine has encouraged healthcare institutions to standardize serum lactate testing as part of routine clinical protocols. At the same time, portable analyzers and continuous monitoring technologies are expanding testing applications beyond centralized laboratories into ambulatory care, home healthcare, sports medicine, and remote healthcare environments.
Technological innovations focused on automation, digital connectivity, wireless data transmission, and enhanced analytical precision continue to improve laboratory efficiency while supporting broader clinical adoption.
Market Drivers
One of the primary drivers of market growth is the increasing global burden of sepsis and other critical illnesses requiring rapid diagnosis and continuous patient monitoring. Early serum lactate assessment plays a crucial role in identifying high-risk patients, guiding therapeutic decisions, and improving clinical outcomes, making it an essential component of emergency and intensive care.
Growing investments in healthcare infrastructure, intensive care units, and advanced diagnostic laboratories are also contributing to increased demand for modern serum lactate testing solutions. Healthcare providers are expanding laboratory capabilities while adopting integrated diagnostic platforms that improve workflow efficiency and clinical decision-making.
Additionally, rising preference for point-of-care testing is encouraging manufacturers to develop compact, portable analyzers capable of delivering rapid and reliable lactate measurements in emergency departments, ambulances, rural healthcare facilities, and disaster response settings. Government initiatives aimed at strengthening emergency healthcare services and improving early disease detection further support market growth.
Business Opportunity
The Serum Lactate Testing Market presents significant opportunities through the development of continuous monitoring technologies, wearable biosensors, and AI-powered diagnostic platforms. As healthcare systems increasingly embrace digital health ecosystems, manufacturers have opportunities to integrate lactate testing with electronic health records (EHRs), remote patient monitoring platforms, and clinical decision support systems.
Emerging economies also offer substantial growth potential as governments continue investing in healthcare modernization and expanding access to advanced diagnostic services. Increasing adoption of hospital-at-home programs, telemedicine, and remote patient monitoring is expected to create new demand for portable, user-friendly serum lactate testing devices.
Manufacturers focusing on affordable, highly accurate, and digitally connected diagnostic solutions are expected to strengthen their market positions across both developed and developing healthcare markets.
Regional Analysis
North America continues to dominate the global Serum Lactate Testing Market, supported by advanced healthcare infrastructure, widespread implementation of sepsis management protocols, and high adoption of point-of-care diagnostic technologies. Strong reimbursement systems and ongoing investments in critical care diagnostics further reinforce regional market leadership.
Europe remains a significant market due to its well-established healthcare systems, increasing clinical awareness of early sepsis detection, and continuous investments in laboratory modernization and diagnostic innovation.
East Asia is expected to experience robust growth, driven by rising healthcare expenditure, improving hospital infrastructure, and increasing adoption of advanced diagnostic technologies across major healthcare facilities.
South Asia & Oceania is emerging as a promising regional market owing to expanding healthcare infrastructure, growing government investments in emergency medical services, and increasing access to modern diagnostic equipment.
Latin America and the Middle East & Africa are anticipated to witness steady market growth as healthcare accessibility improves and hospitals continue investing in advanced diagnostic technologies and critical care facilities.
Competitive Landscape
The global Serum Lactate Testing Market is moderately consolidated, with leading manufacturers competing through technological innovation, diagnostic accuracy, digital integration, and comprehensive service offerings. Companies continue investing in research and development to enhance analyzer performance, improve portability, and enable seamless integration with hospital information systems and connected healthcare platforms.
Strategic collaborations, regulatory approvals, product launches, acquisitions, and expansion into emerging healthcare markets remain key strategies adopted by industry participants to strengthen their competitive positions and expand their global footprint.
Key Players
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Radiometer
- Nova Biomedical
- EKF Diagnostics
- Werfen
- Beckman Coulter
- Mindray Medical International
- bioMerieux
- Sysmex Corporation
- Biolinq
- Hoffmann-La Roche
- Epicore Biosystems
- i-STAT
Future Outlook
The future of the Serum Lactate Testing Market remains promising as healthcare providers increasingly focus on early disease detection, rapid clinical decision-making, and personalized patient care. Continuous advancements in biosensor technologies, wearable monitoring devices, AI-assisted diagnostics, and point-of-care testing platforms are expected to transform the competitive landscape over the coming years.
Growing investments in digital healthcare infrastructure, expanding emergency care services, and increasing awareness of timely sepsis diagnosis and management will continue to drive sustained demand for serum lactate testing solutions throughout the forecast period.
Market Segmentation
By Product Type
- Benchtop Analyzers
- Handheld Meters
- Portable POCT Analyzers
- Test Strips & Cartridges
- Continuous Monitoring Sensors
- Others
By Application
- Sepsis Monitoring
- Sports Performance
- Trauma & Emergency Care
- Post-surgical Care
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Point-of-care Clinics
- Ambulatory Surgical Centers
- Sports Institutes
- Home Care Settings
By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Serum Lactate Testing Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Serum Lactate Testing Market Outlook, 2020-2033
- 3.1. Global Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 3.1.1. Benchtop analyzers
- 3.1.2. Handheld meters
- 3.1.3. Portable POCT analyzers
- 3.1.4. Test strips & cartridge
- 3.1.5. Continuous monitoring sensors
- 3.1.6. Others
- 3.2. Global Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 3.2.1. Sepsis monitoring
- 3.2.2. Sports performance
- 3.2.3. Trauma & emergency care
- 3.2.4. Post-surgical care
- 3.2.5. Others
- 3.3. Global Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 3.3.1. Hospitals
- 3.3.2. Diagnostic laboratories
- 3.4. Global Serum Lactate Testing Market Outlook, by Region, Value (US$ Mn) & Volume (Tons), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Serum Lactate Testing Market Outlook, 2020-2033
- 4.1. North America Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 4.1.1. Benchtop analyzers
- 4.1.2. Handheld meters
- 4.1.3. Portable POCT analyzers
- 4.1.4. Test strips & cartridge
- 4.1.5. Continuous monitoring sensors
- 4.1.6. Others
- 4.2. North America Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 4.2.1. Sepsis monitoring
- 4.2.2. Sports performance
- 4.2.3. Trauma & emergency care
- 4.2.4. Post-surgical care
- 4.2.5. Others
- 4.3. North America Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 4.3.1. Hospitals
- 4.3.2. Diagnostic laboratories
- 4.4. North America Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
- 4.4.1. U.S. Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 4.4.2. U.S. Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 4.4.4. Canada Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 4.4.5. Canada Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Serum Lactate Testing Market Outlook, 2020-2033
- 5.1. Europe Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 5.1.1. Benchtop analyzers
- 5.1.2. Handheld meters
- 5.1.3. Portable POCT analyzers
- 5.1.4. Test strips & cartridge
- 5.1.5. Continuous monitoring sensors
- 5.1.6. Others
- 5.2. Europe Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 5.2.1. Sepsis monitoring
- 5.2.2. Sports performance
- 5.2.3. Trauma & emergency care
- 5.2.4. Post-surgical care
- 5.2.5. Others
- 5.3. Europe Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 5.3.1. Hospitals
- 5.3.2. Diagnostic laboratories
- 5.4. Europe Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
- 5.4.1. Germany Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.2. Germany Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.4. Italy Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.5. Italy Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.7. France Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.8. France Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.9. France Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.10. U.K. Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.11. U.K. Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.13. Spain Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.14. Spain Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.16. Russia Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.17. Russia Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.4.19. Rest of Europe Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 5.4.20. Rest of Europe Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Serum Lactate Testing Market Outlook, 2020-2033
- 6.1. Asia Pacific Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 6.1.1. Benchtop analyzers
- 6.1.2. Handheld meters
- 6.1.3. Portable POCT analyzers
- 6.1.4. Test strips & cartridge
- 6.1.5. Continuous monitoring sensors
- 6.1.6. Others
- 6.2. Asia Pacific Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 6.2.1. Sepsis monitoring
- 6.2.2. Sports performance
- 6.2.3. Trauma & emergency care
- 6.2.4. Post-surgical care
- 6.2.5. Others
- 6.3. Asia Pacific Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 6.3.1. Hospitals
- 6.3.2. Diagnostic laboratories
- 6.4. Asia Pacific Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
- 6.4.1. China Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.2. China Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.3. China Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.4.4. Japan Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.5. Japan Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.4.7. South Korea Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.8. South Korea Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.4.10. India Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.11. India Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.12. India Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.4.13. Southeast Asia Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.14. Southeast Asia Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.4.16. Rest of SAO Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 6.4.17. Rest of SAO Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Serum Lactate Testing Market Outlook, 2020-2033
- 7.1. Latin America Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 7.1.1. Benchtop analyzers
- 7.1.2. Handheld meters
- 7.1.3. Portable POCT analyzers
- 7.1.4. Test strips & cartridge
- 7.1.5. Continuous monitoring sensors
- 7.1.6. Others
- 7.2. Latin America Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 7.2.1. Sepsis monitoring
- 7.2.2. Sports performance
- 7.2.3. Trauma & emergency care
- 7.2.4. Post-surgical care
- 7.2.5. Others
- 7.3. Latin America Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 7.3.1. Hospitals
- 7.3.2. Diagnostic laboratories
- 7.4. Latin America Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
- 7.4.1. Brazil Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 7.4.2. Brazil Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 7.4.4. Mexico Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 7.4.5. Mexico Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 7.4.7. Argentina Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 7.4.8. Argentina Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 7.4.10. Rest of LATAM Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 7.4.11. Rest of LATAM Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Serum Lactate Testing Market Outlook, 2020-2033
- 8.1. Middle East & Africa Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
- 8.1.1. Benchtop analyzers
- 8.1.2. Handheld meters
- 8.1.3. Portable POCT analyzers
- 8.1.4. Test strips & cartridge
- 8.1.5. Continuous monitoring sensors
- 8.1.6. Others
- 8.2. Middle East & Africa Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
- 8.2.1. Sepsis monitoring
- 8.2.2. Sports performance
- 8.2.3. Trauma & emergency care
- 8.2.4. Post-surgical care
- 8.2.5. Others
- 8.3. Middle East & Africa Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
- 8.3.1. Hospitals
- 8.3.2. Diagnostic laboratories
- 8.4. Middle East & Africa Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
- 8.4.1. GCC Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 8.4.2. GCC Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 8.4.4. South Africa Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 8.4.5. South Africa Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 8.4.7. Egypt Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 8.4.8. Egypt Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 8.4.10. Nigeria Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 8.4.11. Nigeria Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 8.4.13. Rest of Middle East Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
- 8.4.14. Rest of Middle East Serum Lactate Testing Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Serum Lactate Testing Market Outlook, by End User, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Roche Diagnostics
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Abbott Laboratories
- 9.4.3. Siemens Healthineers
- 9.4.4. Radiometer
- 9.4.5. Nova Biomedical
- 9.4.6. EKF Diagnostics
- 9.4.7. Werfen Beckman Coulter
- 9.4.8. Mindray Medical International
- 9.4.9. bioMerieux
- 9.4.10. Sysmex Corporation
- 9.4.11. Biolinq
- 9.4.12. Hoffmann-La Roche
- 9.4.13. Epicore Biosystems
- 9.4.14. i-STAT
- 9.4.1. Roche Diagnostics
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
(주말 및 공휴일 제외)
